ArticleJournal of orthopaedic surgery and research2025
Comparison of the effects of hydrogel and normal saline as carriers of MSC on fracture healing in a rat long bone fracture model.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMesenchymal stem cells (MSCs) are used in cell therapy to enhance healing in long bone fractures, where nonunion is highly likely to occur. However, only a few studies have been conducted on carriers that should be used for more effective cell delivery. This study compared the use of hydrogel and normal saline as carriers for enhancing fracture healing when injecting MSC in a long bone fracture rat model.
methodsWistar rats were classified according to the carrier used for MSC injection: Groups C (normal saline) and H (hydrogel). MSCs were administered to the fracture site via direct injection method. The long bone specimens were harvested at 2 and 6 weeks after fracture. Western blot analysis was used to assess the expression of chemokines associated with MSC recruitment (stromal cell-derived factor 1 [SDF-1], monocyte chemoattractant protein-1 [MCP-1]), and osteogenesis (bone morphogenetic protein-2 [BMP-2], transforming growth factor-beta 1 [TGF-β1]) at 2 and 6 weeks post-fracture, respectively. Bone volume [BV], percentage bone volume [PBV] and bone marrow density [BMD]) were evaluated using micro-computed tomography (CT). MSC survival was monitored using fluorescence imaging up to 2 weeks post-fracture.
resultsGroup H demonstrated higher SDF-1 and MCP-1 levels at 2 weeks post-fracture compared with group C. No significant differences in protein expression levels of osteogenesis-related chemokines were observed between the two groups at 6 weeks post-fracture. Micro-CT showed higher BV, PBV and BMD in group H compared with group C at 6 weeks post-fracture. Signals of MSCs injected into fracture site lasted longer in group H until 2 weeks post-fracture and showed higher radiance efficiency in each period than in group C.
conclusionsCompared with using normal saline, using hydrogel significantly enhanced fracture healing in the early phase and formed more new bones at higher densities in the late phase. Injected MSCs were more concentrated around the fracture site and survived longer with hydrogel use than with normal saline use. LEVEL OF EVIDENCE: Level V.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.